North Peak Capital Management, LLC - 31 Mar 2026 SCHEDULE 13G/A Report for HAEMONETICS CORP Common stock, $.01 par value per share (HAE)

Quoteable Key Fact

"North Peak Capital Management, LLC disclosed 0% ownership in HAEMONETICS CORP Common stock, $.01 par value per share (HAE) on 31 Mar 2026."

Quick Takeaways

North Peak Capital Management, LLC filed SCHEDULE 13G/A for HAEMONETICS CORP Common stock, $.01 par value per share (HAE).
Disclosed ownership: 0%.
Date of event: 31 Mar 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Signature	Title
North Peak Capital Management, LLC	0%	/s/ Jeremy Kahan	Jeremy Kahan, Managing Member
North Peak Capital GP, LLC	0%	/s/ Jeremy Kahan	Jeremy Kahan, Manager
North Peak Capital Partners, LP	0%	/s/ Jeremy Kahan	Jeremy Kahan, Manager of North Peak Capital GP, LLC, its General Partner
North Peak Capital Partners II, LP	0%	/s/ Jeremy Kahan	Jeremy Kahan, Manager of North Peak Capital GP, LLC, its General Partner
North Peak Capital Alpha Fund, LP	0%	/s/ Jeremy Kahan	Jeremy Kahan, Manager of North Peak Capital GP, LLC, its General Partner
North Peak Capital Ultra Fund, LP	0%	/s/ Jeremy Kahan	Jeremy Kahan, Manager of North Peak Capital GP, LLC, its General Partner
Michael Kevin Kahan	0%	/s/ Michael Kahan	Michael Kahan
Jeremy Steven Kahan	0%	/s/ Jeremy Kahan	Jeremy Kahan